Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Concordia Healthcare Corp (NASDAQ:CXRX) Analyst Recommendati
View:
Post by Qh1234 on Dec 21, 2015 3:48pm

Concordia Healthcare Corp (NASDAQ:CXRX) Analyst Recommendati

see details in
https://www.thestockreview.com/analyst-watch/concordia-healthcare-corp-nasdaqcxrx-analyst-recommendation-update/6279/
Comment by adamchess on Dec 21, 2015 4:13pm
Another SH alias for health1234, healthstock1234?
Comment by sunshine7 on Dec 21, 2015 4:54pm
A little out of date I think. Although the title is labelled Dec 21, the clue being "In terms of future earnings, analysts are projecting that the firm will report earnings of $1.49 for the current quarter." Of course these were delivered early November so wondering if the SP forecasts are also out of date! Lastly, at that time average forecast was US$61 which is C$85.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities